DEA-Licensed Pharmaceutical Cannabis Company Biopharmaceutical Research Company (BRC) Announces $20M Series A Funding Round. The Company. #BiopharmaceuticalResearchCompany #IntrinsicCapitalPartners
/PRNewswire/ Biopharmaceutical Research Company ("BRC"), an active Drug Enforcement Administration (DEA) pharmaceutical cannabis license holder, announced.